News News

CONTACT:

Sirnaomics, Inc.
Michael Molyneaux MD MBA
Chief Medical Officer
michaelmolyneaux@sirnaomics.com

ICR Healthcare

Investors: Stephanie Carrington
Tel: +1 646 277 1282
Stephanie.Carrington@icrinc.com

Media: Mark Corbae
Tel: 203-682-8288
Email: Mark.Corbae@icrinc.com

Sirnaomics News Placeholder 05
April 26, 2019 Sirnaomics Closes $48 Million Series C Financing to Develop RNAi Therapeutics

Sirnaomics has sealed the C2 round of financing for $22 million. This round of funding was led by CR-CP Life Sciences Fund, a Hong Kong based joint venture established by China Resources Group and Charoen Pokphand Group, two Asian conglomerates.

Sirnaomics News Placeholder 04
April 8, 2019 Sirnaomics to Present at World Orphan Drug Congress 2019

Sirnaomics announced that the Company’s management will present its platform technology and discuss the potential clinical utility of RNAi therapeutics at the World Orphan Drug Congress USA 2019 on April 10-12 in Oxon Hill, Maryland.

Sirnaomics at Opt Congress
March 11, 2019 Sirnaomics to Present at the 4th Annual OPT: Discovery, Development & Delivery

Sirnaomics announced that the Company’s management will present its platform technology and discuss the potential utility of RNAi therapeutics at the 4th Annual Oligonucleotide & Precision Therapeutics: Discovery, Development and Delivery conference on March 25-28, 2019 in Cambridge, Massachusetts.

Sirnaomics AsiaTIDES
February 25, 2019 Sirnaomics to Present Data Demonstrating STP705 Augmentation of Immune Checkpoint Inhibitors in Live

Sirnaomics announced that the Company will present preclinical data from the use of its RNAi technology program in a liver cancer mouse model at AsiaTIDES: Ogligonucleotide & Peptide Therapeutics taking place in Tokyo, Japan on February 28 – March 1, 2019.

Sirnaomics News Placeholder 03
January 30, 2019 Sirnaomics to Present at 2019 BIO CEO & Investor Conference

Sirnaomics announced that the management will present and conduct face-to-face meetings at the 2019 BIO CEO & Investor Conference, to be held in New York, NY on February 11-12.

1 2 3 4 5 9